Status:

UNKNOWN

Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B

Lead Sponsor:

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions:

Chronic Hepatitis B

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of Domestic Tenofovir Disoproxil Fumarate Tablets in Chinese patients with hepatitis B ,compared with Tenofovir Disoproxil Fumarate Tab...

Eligibility Criteria

Inclusion

  • The initial treatment of subjects diagnosed of HBeAg positive or negative chronic hepatitis B
  • Aged 18 to 65 years old,male or female
  • Patients with previously HBsAg-positive lasted for 6months at least:HBeAg-positive subjects, HBV-DNA\> 105copies/ml; HBeAg-negative subjects, HBV-DNA\> 104copies/ml.
  • 2 times the upper normal limit (2 × ULN) ≤ alanine aminotransferase (ALT) ≤ 10 × ULN.
  • Total serum bilirubin (TBIL) ≤ 2.5 × ULN.
  • Prothrombin activity (PTA) ≥ 60% or prothrombin time prolonged than normal ≤ 3 seconds).
  • WBC ≥ 3.5 × 109 / L, PLT ≥ 80 × 109 / L, serum albumin (ALB)≥ 35 g / L.
  • Creatinine (Cr) ≤ 1× ULN,serum phosphate was normal.
  • Patients signed an informed consent form and compliance was good.

Exclusion

  • Patients were infected with other viruses as HAV, HCV, HEV, HIV etc.
  • Patients with cirrhosis or liver cancer.
  • Pregnant woman, lactating women .
  • Patients with severe heart, kidney, endocrine hematopoietic system and neuropsychiatric diseases.
  • Patients with metabolic or autoimmune diseases such as systemic lupus erythematosus.
  • Patients allergic for study drug.

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2019

Estimated Enrollment :

360 Patients enrolled

Trial Details

Trial ID

NCT02287857

Start Date

September 1 2014

End Date

October 1 2019

Last Update

March 19 2019

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

Beijing Ditan Hospital Capital Medical University

Beijing, Beijing Municipality, China, 100015

2

Peking University First Hospital

Beijing, Beijing Municipality, China, 100034

3

Peking University People's Hospital

Beijing, Beijing Municipality, China, 100044

4

Beijing You An Hospital, Capital Medical University

Beijing, Beijing Municipality, China, 100069